ClinicalTrials.govpublic full text
RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS
multiple sclerosis, relapsing-remitting, multiple sclerosis, relapsing-remitting, dosing protocols, randomized trial, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877671
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.